News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Andrea R. Genazzani, MD

Advertisement

Articles by Andrea R. Genazzani, MD

Discussing Hormone Replacement Therapy

ByMark Perloe, MD,Bruno Lunenfeld, MD,Andrea R. Genazzani, MD,Howard Carp, MD
September 6th 2006

OBGYN.net Conference CoverageFrom First Congress on Controversies in Obstetrics, Gynecology & Infertility Prague CZECH REPUBLIC - October, 1999

Advertisement

Latest Updated Articles

  • Discussing Hormone Replacement Therapy
    Discussing Hormone Replacement Therapy

    Published: September 6th 2006 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Review finds no evidence linking prenatal paracetamol use to increased risk of autism, ADHD

2

FDA approves 5-year use for etonogestrel implant 68 mg contraceptive

3

LPCN 1154 for postpartum depression continues clinical process after safety review

4

Interim safety data of RSVpreF vaccination during pregnancy, with Ashley Michnick, PharmD, PhD

5

Jennifer Karlin, MD, PhD, explains barriers, biases for user-administered injectable contraceptives

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us